IMPROVEMENTS IN MAJOR CLINICAL EVENTS IN CHILDREN TREATED WITH TRIHEPTANOIN FOR LONG-CHAIN FATTY ACID OXIDATION DISORDERS (LC-FAOD)

被引:0
|
作者
Ray, Kathryn [1 ]
Pisani, Laura [1 ]
Lu, Xiaoxiao [1 ]
Vockley, Jerry [2 ]
机构
[1] Ultragenyx Pharmaceut Inc, Novato, CA USA
[2] Univ Pittsburgh, Sch Med, UPMC Childrens Hosp Pittsburgh, Pittsburgh, PA USA
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
75
引用
收藏
页码:295 / 296
页数:2
相关论文
共 50 条
  • [31] Physiological Perspectives on the Use of Triheptanoin as Anaplerotic Therapy for Long Chain Fatty Acid Oxidation Disorders
    Sklirou, Evgenia
    Alodaib, Ahmad N.
    Dobrowolski, Steven F.
    Mohsen, Al-Walid A.
    Vockley, Jerry
    FRONTIERS IN GENETICS, 2021, 11
  • [32] Correction to: Triheptanoin in the management of long‑chain fatty acid oxidation disorders: a profile of its use
    Esther S. Kim
    Susan J. Keam
    Drugs & Therapy Perspectives, 2021, 37 : 282 - 282
  • [33] Triheptanoin for the treatment of long-chain fatty acid oxidation disorders: Final results of an open-label, long-term extension study
    Vockley, Jerry
    Burton, Barbara K. K.
    Berry, Gerard
    Longo, Nicola
    Phillips, John
    Sanchez-Valle, Amarilis
    Chapman, Kimberly A. A.
    Tanpaiboon, Pranoot
    Grunewald, Stephanie
    Murphy, Elaine
    Lu, Xiaoxiao
    Rahman, Syeda
    Ray, Kathryn
    Reineking, Bridget
    Pisani, Laura
    Ramirez, Antonio Nino
    JOURNAL OF INHERITED METABOLIC DISEASE, 2023, 46 (05) : 943 - 955
  • [34] Neurological outcome in long-chain hydroxy fatty acid oxidation disorders
    Muetze, Ulrike
    Ottenberger, Alina
    Gleich, Florian
    Maier, Esther M.
    Lindner, Martin
    Husain, Ralf A.
    Palm, Katja
    Beblo, Skadi
    Freisinger, Peter
    Santer, Rene
    Thimm, Eva
    vom Dahl, Stephan
    Weinhold, Natalie
    Grohmann-Held, Karina
    Haase, Claudia
    Hennermann, Julia B.
    Hoerbe-Blindt, Alexandra
    Kamrath, Clemens
    Marquardt, Iris
    Marquardt, Thorsten
    Behne, Robert
    Haas, Dorothea
    Spiekerkoetter, Ute
    Hoffmann, Georg F.
    Garbade, Sven F.
    Gruenert, Sarah C.
    Koelker, Stefan
    ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY, 2024, 11 (04): : 883 - 898
  • [35] Disorders of mitochondrial long-chain fatty acid oxidation and the carnitine shuttle
    Suzan J. G. Knottnerus
    Jeannette C. Bleeker
    Rob C. I. Wüst
    Sacha Ferdinandusse
    Lodewijk IJlst
    Frits A. Wijburg
    Ronald J. A. Wanders
    Gepke Visser
    Riekelt H. Houtkooper
    Reviews in Endocrine and Metabolic Disorders, 2018, 19 : 93 - 106
  • [36] Long-Chain Fatty Acid Oxidation Disorders and Current Management Strategies
    Vockley, Jerry
    AMERICAN JOURNAL OF MANAGED CARE, 2020, 26 (07): : S147 - S154
  • [37] Disorders of mitochondrial long-chain fatty acid oxidation and the carnitine shuttle
    Knottnerus, Suzan J. G.
    Bleeker, Jeannette C.
    Wust, Rob C. I.
    Ferdinandusse, Sacha
    IJlst, Lodewijk
    Wijburg, Frits A.
    Wanders, Ronald J. A.
    Visser, Gepke
    Houtkooper, Riekelt H.
    REVIEWS IN ENDOCRINE & METABOLIC DISORDERS, 2018, 19 (01): : 93 - 106
  • [38] Muscle MRI in patients with long-chain fatty acid oxidation disorders
    Diekman, Eugene F.
    van der Pol, W. Ludo
    Nievelstein, Rutger A. J.
    Houten, Sander M.
    Wijburg, Frits A.
    Visser, Gepke
    JOURNAL OF INHERITED METABOLIC DISEASE, 2014, 37 (03) : 405 - 413
  • [39] Mitochondrial fatty acid oxidation disorders: clinical presentation of long-chain fatty acid oxidation defects before and after newborn screening
    Spiekerkoetter, Ute
    JOURNAL OF INHERITED METABOLIC DISEASE, 2010, 33 (05) : 527 - 532
  • [40] Triheptanoin treatment in patients with pediatric cardiomyopathy associated with long chain-fatty acid oxidation disorders
    Vockley, J.
    Charrow, J.
    Ganesh, J.
    Eswara, M.
    Diaz, G. A.
    McCracken, E.
    Conway, R.
    Enns, G. M.
    Starr, J.
    Wang, R.
    Abdenur, J. E.
    Sanchez-de-Toledo, J.
    Marsden, D. L.
    MOLECULAR GENETICS AND METABOLISM, 2016, 119 (03) : 223 - 231